Nymox Pharmaceutical (NYMXF) Return on Equity [ROE] (2018 - 2022)
Nymox Pharmaceutical (NYMXF) reported Return on Equity [ROE] of -4519.59% for Q4 2022, down 2191.45 percentage points from -2328.13% a year earlier and down 3984.01 percentage points from the prior quarter.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Return on Equity [ROE] (2018 - 2022) Analysis & Trends
For FY2021, Nymox Pharmaceutical posted Return on Equity [ROE] of -1529.84%, down 1110.10 percentage points from FY2020.
- Return on Equity [ROE] has a three-year change of -1161.41 percentage points (FY2018 to FY2021).
- By year, Return on Equity [ROE] came in at -419.74% in FY2020 (-167.83 pp), -251.90% in FY2019 (+116.52 pp) and -368.42% in FY2018.
- The Q4 2022 figure ranks as the lowest quarterly Return on Equity [ROE] since Q2 2020.
- Year over year, Return on Equity [ROE] has now declined in each of the last three quarters, with an average year-over-year change of -307.10 percentage points over the last seven quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2021 (a gain of 5140.73 percentage points); the low point was Q2 2020 (a drop of 5524.76 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 4.97% |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -4,519.59% |
| Sep 30, 2022 | -535.57% |
| Jun 30, 2022 | -2,340.62% |
| Dec 31, 2021 | -2,328.13% |
| Sep 30, 2021 | -373.74% |
| Jun 30, 2021 | -537.25% |
| Mar 31, 2021 | -1,084.11% |
| Dec 31, 2020 | -57.84% |
| Sep 30, 2020 | -66.34% |
| Jun 30, 2020 | -5,677.98% |
| Mar 31, 2020 | -528.00% |
| Dec 31, 2019 | -289.34% |
| Sep 30, 2019 | -199.70% |
| Jun 30, 2019 | -153.22% |
| Mar 31, 2019 | -126.38% |
| Dec 31, 2018 | -193.82% |
| Sep 30, 2018 | -299.48% |
| Jun 30, 2018 | -1,036.54% |
API Access
Nymox Pharmaceutical Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();